Metrikler
Yayın
67
Açık Erişim
4
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2014 - 2018
2014 - 2018Doktora
Marmara Üniversitesi, Fen Bilimleri Enstitüsü, Türkiye
2012 - 2014
2012 - 2014Yüksek Lisans
Marmara Üniversitesi, Fen Bilimleri Enstitüsü, Türkiye
2006 - 2011
2006 - 2011Lisans
Ege Üniversitesi, Mühendislik Fakültesi, Biyomühendislik Bölümü, Türkiye
Yaptığı Tezler
2018
2018Doktora
Systems biomedicine and pharmacology approaches for drug repositioning to uncover candidate anti-cancer drugs 
Marmara Üniversitesi, Fen Bilimleri Enstitüsü
2014
2014Yüksek Lisans
Purification and characterization of levansucrase by Halomonas smyrnensis AAD6T
Marmara Üniversitesi, Fen Bilimleri Enstitüsü, Biyomühendislik (İngilizce) Anabilim Dalı
Yabancı Diller
C2 Ustalık
C2 Ustalıkİngilizce
Araştırma Alanları
Biyokimya
Biyoinformatik
Biyoenformasyon
Biyolojik Modelleme
Biyolojik Veritabanları
Biyoteknoloji
Genomiks
Kanser Moleküler Biyolojisi
Akademik Ünvanlar / Görevler
2020 - Devam Ediyor
2020 - Devam EdiyorDr. Öğr. Üyesi
Marmara Üniversitesi, Mühendislik Fakültesi, Biyomühendislik Bölümü
2012 - 2020
2012 - 2020Araştırma Görevlisi
İstanbul Medeniyet Üniversitesi, Mühendislik Ve Doğa Bilimleri Fakültesi, Biyomühendislik
Akademi Dışı Deneyim
2017 - 2018
2017 - 2018Visiting Researcher
KTH, Visiting Researcher
Makaleler
Tümü (40)
SCI-E, SSCI, AHCI (38)
SCI-E, SSCI, AHCI, ESCI (39)
ESCI (2)
Scopus (39)
Diğer Yayınlar (1)
2025
20251. Gaining Biological Insights Into Deltamethrin-Induced Toxicity and Resistance at the Molecular Level
Yavuz M., Kaya R. A., BEREKETOĞLU C., TURANLI B.
Journal of Biochemical and Molecular Toxicology
, cilt.39, sa.9, 2025 (SCI-Expanded)
2025
20252. The Construction of ceRNA Regulatory Network Unraveled Prognostic Biomarkers and Repositioned Drug Candidates for the Management of Pancreatic Ductal Adenocarcinoma
Aydin B., Okutan K., Aydogan O. O., Sinha R., TURANLI B.
Current Issues in Molecular Biology
, cilt.47, sa.7, 2025 (SCI-Expanded)
2024
20243. Public health challenges after the February 6 earthquakes: A comprehensive review of immediate and long-term impacts in Türkiye
Koçer A. T., Akpek A., Vural A., Aslan A., Erkoç A., Özen A. M., et al.
International Journal of Disaster Risk Reduction
, cilt.114, 2024 (SCI-Expanded)
2024
20244. Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities
Budak B., Tükel E. Y., TURANLI B., Kiraz Y.
Annals of Hematology
, cilt.103, sa.10, ss.4121-4134, 2024 (SCI-Expanded)
2024
20245. Comparative analysis of diisononyl phthalate and di(isononyl)cyclohexane-1,2 dicarboxylate plasticizers in regulation of lipid metabolism in 3T3-L1 cells
BEREKETOĞLU C., Häggblom I., TURANLI B., Pradhan A.
Environmental Toxicology
, cilt.39, sa.3, ss.1245-1257, 2024 (SCI-Expanded)
2024
20246. DCDA: CircRNA–Disease Association Prediction with Feed-Forward Neural Network and Deep Autoencoder
Turgut H., TURANLI B., BOZ B.
Interdisciplinary Sciences – Computational Life Sciences
, cilt.16, sa.1, ss.91-103, 2024 (SCI-Expanded, Scopus)
2024
20247. Genome-scale metabolic models in translational medicine: the current status and potential of machine learning in improving the effectiveness of the models
TURANLI B., Gulfidan G., Aydogan O. O., KULA C., Selvaraj G., ARGA K. Y.
Molecular Omics
, cilt.20, sa.4, ss.234-247, 2024 (SCI-Expanded, Scopus)
2023
20238. Decoding Systems Biology of Inflammation Signatures in Cancer Pathogenesis: Pan-Cancer Insights from 12 Common Cancers
TURANLI B.
Omics : a journal of integrative biology
, cilt.27, sa.10, ss.483-493, 2023 (SCI-Expanded)
2023
20239. Idiopathic Pulmonary Fibrosis Molecular Substrates Revealed by Competing Endogenous RNA Regulatory Networks
Kircali M. F., TURANLI B.
OMICS A Journal of Integrative Biology
, cilt.27, sa.8, ss.381-392, 2023 (SCI-Expanded, Scopus)
2023
202310. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B., Beklen H., Arga K. Y., Bayrakli F., Turanli B.
Journal of endocrinological investigation
, cilt.46, ss.727-747, 2023 (SCI-Expanded)
2023
202311. Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer.
Kori M., Turanli B., Arga K. Y.
Frontiers in oncology
, cilt.13, ss.1096081, 2023 (SCI-Expanded)
2022
202212. Prospects of integrated multi-omics-driven biomarkers for efficient hair loss therapy from systems biology perspective
Yilmaz D. N., Aydogan O. O., Kori M., Aydin B., Rahman M. R., Moni M. A., et al.
GENE REPORTS
, cilt.28, 2022 (ESCI)
2022
202213. Acute Myeloid Leukemia: New Multiomics Molecular Signatures and Implications for Systems Medicine Diagnostics and Therapeutics Innovation
Kelesoglu N., Kori M., TURANLI B., ARĞA K. Y., Yilmaz B., Duru O. A.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
, cilt.26, sa.7, ss.392-403, 2022 (SCI-Expanded, Scopus)
2022
202214. Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
Kori M., ARĞA K. Y., Mardinoglu A., TURANLI B.
FRONTIERS IN PHARMACOLOGY
, cilt.13, 2022 (SCI-Expanded)
2022
202215. Past, Present, and Future of Therapies for Pituitary Neuroendocrine Tumors: Need for Omics and Drug Repositioning Guidance
Aydin B., Yildirim E., ERDOĞAN O., ARĞA K. Y., Yilmaz B., BOZKURT S., et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
, cilt.26, sa.3, ss.115-129, 2022 (SCI-Expanded)
2022
202216. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks
Gulfidan G., Soylu M., Demirel D., Erdonmez H. B. C., Beklen H., ÖZBEK SARICA P., et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
, cilt.715, 2022 (SCI-Expanded, Scopus)
2021
202117. Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers
beklen h., arslan s., Gulfidan G., Turanlı B., ÖZBEK SARICA P., Karademir Yılmaz B., et al.
Frontiers in Bioinformatics
, cilt.1, 2021 (Hakemli Dergi)
2021
202118. Differential Protein Interactome in Esophageal Squamous Cell Carcinoma Offers Novel Systems Biomarker Candidates with High Diagnostic and Prognostic Performance
Gulfidan G., Beklen H., Sinha I., Kucukalp F., Caloglu B., Esen I., et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
, cilt.25, ss.495-512, 2021 (SCI-Expanded)
2021
202119. Systems-level biomarkers identification and drug repositioning in colorectal cancer
Beklen H., Yildirim E., Kori M., TURANLI B., ARĞA K. Y.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
, cilt.13, sa.7, ss.638-661, 2021 (SCI-Expanded)
2021
202120. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers.
Kori M., Aydin B., Gulfidan G., Beklen H., Kelesoglu N., Caliskan Iscan A., et al.
Omics : a journal of integrative biology
, cilt.25, sa.3, ss.139-168, 2021 (SCI-Expanded)
2021
202121. Current State of "Omics" Biomarkers in Pancreatic Cancer
TURANLI B., Yildirim E., Gulfidan G., ARĞA K. Y., Sinha R.
JOURNAL OF PERSONALIZED MEDICINE
, cilt.11, sa.2, 2021 (SCI-Expanded)
2021
202122. Systems biology based drug repositioning for development of cancer therapy.
Turanli B., Altay O., Borén J., Turkez H., Nielsen J., Uhlen M., et al.
Seminars in cancer biology
, cilt.68, ss.47-58, 2021 (SCI-Expanded)
2020
202023. Comprehensive Analysis of RNA-Seq Gene Expression Profiling of Brain Transcriptomes Reveals Novel Genes, Regulators, and Pathways in Autism Spectrum Disorder
Rahman M. R., Petralia M. C., Ciurleo R., Bramanti A., Fagone P., Shahjaman M., et al.
BRAIN SCIENCES
, cilt.10, sa.10, 2020 (SCI-Expanded)
2020
202024. Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
Beklen H., Gulfidan G., ARĞA K. Y., Mardinoglu A., Turanli B.
FRONTIERS IN ONCOLOGY
, cilt.10, 2020 (SCI-Expanded)
2020
202025. Pan-cancer mapping of differential protein-protein interactions
Gulfidan G., Turanli B., Beklen H., Sinha R., Arga K. Y.
SCIENTIFIC REPORTS
, cilt.10, sa.1, 2020 (SCI-Expanded)
2020
202026. Classification of clear cell renal cell carcinoma based on PKM alternative splicing
Li X., TURANLI B., Juszczak K., Kim W., Arif M., Sato Y., et al.
HELIYON
, cilt.6, sa.2, 2020 (SCI-Expanded)
2019
201927. Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
Turanli B., Karagoz K., Bidkhori G., Sinha R., Gatza M., Uhlen M., et al.
FRONTIERS IN GENETICS
, cilt.10, 2019 (SCI-Expanded, Scopus)
2019
201928. Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
Turanli B., Zhang C., Kim W., Benfeitas R., Uhlen M., Arga K. Y., et al.
EBIOMEDICINE
, cilt.42, ss.386-396, 2019 (SCI-Expanded)
2019
201929. Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer's disease
Rahman M. R., Islam T., TURANLI B., Zaman T., Faruquee H. M., Rahman M. M., et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY
, cilt.78, ss.431-439, 2019 (SCI-Expanded)
2019
201930. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis
Rahman M. R., Islam T., Gov E., Turanli B., Gulfidan G., Shahjaman M., et al.
MEDICINA-LITHUANIA
, cilt.55, sa.1, 2019 (SCI-Expanded)
2018
201831. Drug Targeting and Biomarkers in Head and Neck Cancers: Insights from Systems Biology Analyses
İSLAM T., RAHMAN R., GÖV E., TURANLI B., GÜLFİDAN G., HAQUE M. A., et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
, cilt.22, sa.6, ss.422-436, 2018 (SCI-Expanded)
2018
201832. Drug Repositioning for Effective Prostate Cancer Treatment
TURANLI B., Grotli M., BOREN J., NIELSEN J., UHLEN M., ARĞA K. Y., et al.
FRONTIERS IN PHYSIOLOGY
, cilt.9, 2018 (SCI-Expanded)
2018
201833. Systems biomarkers in psoriasis: Integrative evaluation of computational and experimental data at transcript and protein levels
Sevimoglu T., Turanli B., Bereketoglu C., ARĞA K. Y., KARADAĞ A. S.
GENE
, cilt.647, ss.157-163, 2018 (SCI-Expanded)
2018
201834. A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine
TURANLI B., Karagoz K., Gulfidan G., Sinha R., Mardinoglu A., ARĞA K. Y.
CURRENT PHARMACEUTICAL DESIGN
, cilt.24, sa.32, ss.3778-3790, 2018 (SCI-Expanded)
2017
201735. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma
Turanli B., Gulfidan G., ARĞA K. Y.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
, cilt.21, sa.10, ss.584-591, 2017 (SCI-Expanded)
2017
201736. Impact of SRT on the efficiency and microbial community of sequential anaerobic and aerobic membrane bioreactors for the treatment of textile industry wastewater
Yurtsever A., Calimlioglu B., ŞAHİNKAYA E.
CHEMICAL ENGINEERING JOURNAL
, cilt.314, ss.378-387, 2017 (SCI-Expanded)
2017
201737. Simultaneous nitrate and perchlorate removal from groundwater by heterotrophic-autotrophic sequential system
Ucar D., Çokgör E., ŞAHİNKAYA E., Cetin U., Bereketoglu C., Calimlioglu B., et al.
INTERNATIONAL BIODETERIORATION & BIODEGRADATION
, cilt.116, ss.83-90, 2017 (SCI-Expanded)
2016
201638. Effect of NaCl concentration on the performance of sequential anaerobic and aerobic membrane bioreactors treating textile wastewater
YURTSEVER A., Calimlioglu B., GÖRÜR M., ÇINAR Ö., Sahinkaya E.
CHEMICAL ENGINEERING JOURNAL
, cilt.287, ss.456-465, 2016 (SCI-Expanded)
2015
201539. Tissue-Specific Molecular Biomarker Signatures of Type 2 Diabetes: An Integrative Analysis of Transcriptomics and Protein-Protein Interaction Data
Calimlioglu B., Karagoz K., Sevimoglu T., Kilic E., Gov E., ARĞA K. Y.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
, cilt.19, sa.9, ss.563-573, 2015 (SCI-Expanded)
2013
201340. Simultaneous bioreduction of nitrate and chromate using sulfur-based mixotrophic denitrification process
ŞAHİNKAYA E., Kilic A., Calimlioglu B., TOKER Y.
JOURNAL OF HAZARDOUS MATERIALS
, cilt.262, ss.234-239, 2013 (SCI-Expanded)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2025
20251. Dİ(İZONONİL) SİKLOHEKSAN-1,2-DİKARBOKSİLAT MARUZİYETİ, ZEBRA BALIKLARINDA BÜYÜME İLE İLİŞKİLİ GEN İFADELERİNİ DEĞİŞTİRİR
Göyük Y., TURANLI B., BEREKETOĞLU C.
8. INTERNATIONAL FOOD, AGRICULTURE AND VETERINARY SCIENCES CONGRESS, Konya, Türkiye, 29 Mayıs 2025, (Tam Metin Bildiri)
2023
20232. Systems Biology Perspective of Gender Biases in Papillary Thyroid Cancer Diagnosis, Prognosis and Therapy
TURANLI B.
V. International Agricultural, Biological & Life Science Conference, Edirne, Türkiye, 18 - 20 Eylül 2023, (Özet Bildiri)
2022
20223. Network Based Integration of Multi-Omic Profiles to Purpose New Biomarker Candidates in Pancreatic Cancer
Yildirim Sirkeci E., TURANLI B.
5th International Eurasian Conference on Biological ad Chemical Sciences (EurasianBioChem)), Ankara, Türkiye, 23 - 25 Kasım 2022, (Tam Metin Bildiri)
2022
20224. Transcriptomics-Based Drug Repurposing Unravels Novel Therapeutic Strategies in AML
KELEŞOĞLU N., Korkmaz N. S., TURANLI B., ARĞA K. Y., YILMAZ B., ATEŞ DURU Ö.
4th EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 3 - 06 Kasım 2022, (Özet Bildiri)
2022
20225. Comparative Study on Understanding Molecular Signatures of ALL and Philedelphia Positive ALL in Adults
BUDAK B., KİRAZ Y., TURANLI B.
4th EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 3 - 06 Kasım 2022, (Özet Bildiri)
2022
20226. Multi-Omics Data Integration to Unveil Molecular Signatures and Repositioned Therapeutics in Pituitary Neuroendocrine Tumors
AYDIN B., TURANLI B.
BIOINFO 2022 Annual Conference, Daejeon, Güney Kore, 19 - 21 Ekim 2022, (Özet Bildiri)
2022
20227. Systems Biology Perspective for Elucidation of Secreted Protein Biomarkers in Alzheimer’s Disease
TURANLI B.
2nd International Natural Science, Engineering and Material Technologies Conference, Kırklareli, Türkiye, 15 - 17 Eylül 2022, (Özet Bildiri)
2021
20218. Novel Systems Biomarker Candidates with High Diagnostic and Prognostic Performance in Esophageal Squamous Cell Carcinoma
GULFİDAN G., BEKLEN H., TURANLI B., AYYILDIZ D., Sinha R., ARĞA K. Y.
3rd EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 4 - 07 Kasım 2021, (Özet Bildiri)
2021
20219. Identification of Cervical Cancer Sub-Type Specific Molecular Targets, Biomarkers and Repurposed Drug Candidates
TURANLI B.
3rd EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 4 - 07 Kasım 2021, (Özet Bildiri)
2021
202110. Differential Interactome Based Drug Repositioning Unraveled Potential Therapeutics for Colorectal Cancers
BEKLEN H., Arslan S., GULFİDAN G., TURANLI B., ÖZBEK SARICA P., YILMAZ B., et al.
3rd EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 4 - 07 Kasım 2021, (Özet Bildiri)
2021
202111. Decoding molecular signatures of pituitary neuroendocrine tumors’ subtypes through systems biomedicine perspective
AYDIN B., Yildirim Sirkeci E., ERDOĞAN O., BAYRAKLI F., BOZKURT S., ARĞA K. Y., et al.
5th International Symposium on Bioinformatics (InSyB2021), İstanbul, Türkiye, 15 - 17 Aralık 2021, (Özet Bildiri)
2020
202012. Drug Respositioning in Colorectal Cancer by using Co-expression Networks of P-glycoprotein
BEKLEN H., GÜLFİDAN G., ARĞA K. Y., NIELSEN J., TURANLI B.
13th The International Symposium on Health Informatics and Bioinformatics, Türkiye, 22 - 23 Ekim 2020, (Özet Bildiri)
2020
202013. DRUG REPOSITIONING IN PROSTATE CANCER THROUGH GENOME-SCALE METABOLIC MODELING
AYDOĞMUŞ E. M., gülfidan g., TURANLI B., ERZİK C., DEMİR Ü., KISAAYAK ÇOLLAK F., et al.
applied bioinformatics in life sciences, Leuven, Belçika, 13 - 14 Şubat 2020
2019
201914. Identification of Systems Biomarkers and Candidate Drugs in Prostate Adenocarcinoma
GULFİDAN G., BEKLEN H., TURANLI B., ARĞA K. Y.
The 12th International Symposium on Health Informatics and Bioinformatics (HIBIT 2019), İzmir, Türkiye, 17 - 19 Ekim 2019, (Özet Bildiri)
2019
201915. Determination Of Candidate Biomarkers Through Differential Interactome in Colorectal Adenocarcinoma
BEKLEN H., GULFİDAN G., TURANLI B., ÖZBEK SARICA P., YILMAZ B., ARĞA K. Y.
The 12th International Symposium on Health Informatics and Bioinformatics (HIBIT 2019), İzmir, Türkiye, 17 - 19 Ekim 2019, (Özet Bildiri)
2019
201916. Drug Repositioning And Docking Studies on Melanoma
İmat N. B., TURANLI B., ACUNER ZORLUUYSAL S. E.
The 12th International Symposium on Health Informatics and Bioinformatics (HIBIT 2019), İzmir, Türkiye, 17 - 19 Ekim 2019, (Özet Bildiri)
2019
201917. Drug repositioning for cancer therapy by the employment of systems biology
TURANLI B., GULFİDAN G., Mardinoğlu A., ARĞA K. Y.
Cell Death: Degeneration and Regeneration Symposium, İstanbul, Türkiye, 3 - 05 Ekim 2019, (Özet Bildiri)
2015
201518. Sistem biyotıp araştırmaları için bütünleştirilmiş biyolojik ağlar yaklaşımı
ÇALIMLIOĞLU B., ARĞA K. Y.
4. ULUSAL MOLEKÜLER BİYOLOJİ VE BİYOTEKNOLOJİ KONGRESİ, Türkiye, 21 - 24 Ağustos 2015, (Özet Bildiri)
2015
201519. Multi Omic Stratejiler Yardımıyla Endometriyozis Hastalığı için Biyobelirteç Tayini
Kori M., ÇALIMLIOĞLU B., ARĞA K. Y.
4. Ulusal Moleküler Biyoloji ve Biyoteknoloji, Türkiye, 21 - 24 Ağustos 2015, (Özet Bildiri)
2015
201520. Metabolic Variability Analysis Through Human Metabolic Model
ISLER E., Yavuz U., ÇALIMLIOĞLU B., ARĞA K. Y.
3rd International Gen-Arel Molecular Biology and Genetics Student Congress, 24 - 25 Nisan 2015
2015
201521. Genomic and Proteomic Candidate Biomarker Investigation for Personalized Medicine
Baran B., AKBAS M., ÇALIMLIOĞLU B., ARĞA K. Y.
3rd International Gen-Arel Molecular Biology and Genetics Student Congress, 24 - 25 Nisan 2015
2013
201322. A novel levansucrase purified from halophilic bacteria halomonas smyrnensis AAD6T
TURANLI B., ARĞA K. Y., TOKSOY ÖNER E.
10th Carbohydrate Bioengineering Meeting (CBM10), Prague, Çek Cumhuriyeti, 21 - 24 Nisan 2013, (Özet Bildiri)
2012
201223. Determining Anti-apoptotic Efficacy of Bcl-xL Protein Encoded by a Dual Promoter Mammalian Expression Vector Developed For Biotechnological Applications
TURANLI B., GÜLÇE İZ S., GÜRHAN S. İ.
6th International Molecular Biology and Genetic Student Congress, İstanbul, Türkiye, 27 - 30 Ağustos 2012, (Özet Bildiri)
2012
201224. Use Of Microbial Fuel Cells For Electricity Generation From Wastewaters
TURANLI B., AĞIR İ., TOKER Y., ŞAHİNKAYA E., ÖZKAYA B.
2nd International 100% Renewable Energy Conference and Exhibition (IRENEC2012), İstanbul, Türkiye, 28 - 30 Haziran 2012, (Özet Bildiri)
Kitaplar
2017
20171. Systems Biomedicine: From genome scale molecular networks to efficacious biomarkers and therapeutic targets
TURANLI B., GÜLFİDAN G., ARĞA K. Y.
Researches on Science and Art in 21st Century Turkey, Hasan Arapgirlioğlu Atilla Atık Robert L. Elliot Edward Turgeon, Editör, Gece Kitaplığı, Ankara, ss.2380-2388, 2017
2016
20162. Proteins from Halophilic Bacteria: Purification and Their Applications
Turanlı B., Arğa K. Y.
Protein Purification - Principles and Trends, -, Editör, iConcept Press, Victoria-City, ss.1-23, 2016
Desteklenen Projeler
2022 - 2024
2022 - 2024Pestisitlerin mayalar üzerindeki toksisitesinin moleküler düzeyde araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Doktora
Bereketoğlu C., Yavuz M., Turanlı B. (Yürütücü)
2021 - 2024
2021 - 2024Nanoplastiklerin Saccharomyces Cerevisiae Üzerindeki Toksik Etkilerinin Araştırılması Ve Crispr Yöntemi Ile Toksisitede Kilit Rol Oynayan Metabolik Yol Izlerinin Manipülasyonu
TÜBİTAK Projesi , 1001 - Bilimsel ve Teknolojik Araştırma Projelerini Destekleme Programı
Bereketoğlu C., Turanlı B., Mertoğlu B. (Yürütücü)
2021 - 2023
2021 - 2023Akut Lenfoblastik Lösemilerde İlaç Yeniden Konumlandırma ile Tedavi Etkinliğinin Artırılması
TÜBİTAK Projesi , 3501 - Ulusal Genç Araştırmacı Kariyer Geliştirme Programı
Turanlı B., Kiraz Durmaz Y.(Yürütücü)
2020 - 2021
2020 - 2021
Drug repositioning for cervical cancer subtypes via host-pathogen interactions and genome-scale metabolic modelling
TÜBİTAK Projesi , 1002 - Hızlı Destek Programı
Turanlı B. (Yürütücü), Arğa K. Y.
2019 - 2020
2019 - 2020Ardışık Sabit Yataklı Anaerobik ve Aerobik Biyoreaktörlerde Metal İşleme Endüstrisi Atıksularının Arıtımı ve Mikrobiyal Popülasyonun Yenilikçi Moleküler Tekniklerle Belirlenmesi
TÜBİTAK Projesi , 1002 - Hızlı Destek Programı
Turanlı B., Toksoy Başaran S.(Yürütücü)
2018 - 2019
2018 - 2019Evsel atıklardan biyoetanol üretim sürecinde enerji ve enzim sarfiyatının optimizasyonu
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
Turanlı B., Uçar D.(Yürütücü), Çoban I.
2017 - 2019
2017 - 2019
Sistem Biyolojisi Bakışı Ile Farklı Seviyelerde Biyolojik Moleküller Üzerinden Prostat Kanseri Için Ilaç Repozisyonu Uygulamaları
TÜBİTAK Projesi , 1001 - Bilimsel ve Teknolojik Araştırma Projelerini Destekleme Programı
Arğa K. Y. (Yürütücü), Kısaayak Çollak F., Erzik C., Demir Ü., Turanlı B.
2017 - 2018
2017 - 2018
Hesaplamalı Sistem Biyolojisi Yaklaşımı Ile Kanser Ilintili Işaretçi Moleküllerin Tespiti Ve Haritalanması
TÜBİTAK Projesi , 1002 - Hızlı Destek Programı
Arğa K. Y. (Yürütücü), TURANLI B.
2016 - 2018
2016 - 2018
Aday kanser karşıtı ilaçların bulunması için sistem biyotıp ve farmakolojisi yaklaşımı ile ilaç repozisyonu
Yükseköğretim Kurumları Destekli Proje , BAP Doktora
Arğa K. Y. (Yürütücü), TURANLI B.
Burslar
2017 - 2018
2017 - 20182214-A Yurt Dışı Araştırma Burs Programı
TÜBİTAK
2014 - 2017
2014 - 2017